Kalshi· Science and Technology

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

Chance

80%

Buy Yes

92¢

pays $1 if it happens

Buy No

32¢

pays $1 if it doesn’t

Prices from Kalshi, updated 15 minutes ago. Ends Jan 1, 4:59 AM UTC.

Price over the last 2 weeks

Cost of a Yes share

How this market is decidedShow

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.